RxSight
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of RxSight generated cash of -$41,593,000, which is more than the previous year. Cash used in financing activities reached the amount of $61,524,000 last year. Net change in cash is therefore -$2,192,000.
Cash Flow
| 2019 | -40.61M | -5.87M | 1.33M |
|---|---|---|---|
| 2020 | -35.20M | 15.59M | 25.23M |
| 2021 | -44.70M | -81.90M | 137.34M |
| 2022 | -58.85M | 39.95M | 6.33M |
| 2023 | -41.59M | -22.12M | 61.52M |
RXST Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 12.59M | 25.17M | 14.45M | 8.83M | 53.98M |
Operating activities | |||||
Net income | -48.60M | -66.75M | -48.68M | 27.57M | 126.22M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 4.24M | 4.02M | 3.98M | 4.01M | 3.93M |
Stock-based compensation expense | 15.74M | 11.39M | 7.57M | 4.18M | 4.59M |
| Deferred income tax benefit | 15.74M | 11.39M | 7.57M | 4.18M | 4.59M |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -9.32M | -6.09M | -1.99M | -2.07M | -789K |
Inventories | -2.74M | -7.55M | -2.11M | -1.30M | -5.47M |
Accounts payable | 1.25M | 635K | 555K | -954K | 1.13M |
Cash generated by operating activities | -41.59M | -58.85M | -44.70M | -35.20M | -40.61M |
Investing activities | |||||
Purchases Of Investments | -272.31M | -212.65M | -159.96M | -97.87M | -132.38M |
Investments In Property Plant And Equipment | -4.81M | -2.39M | -1.94M | -2.53M | -4.08M |
Acquisitions Net | 17.31M | -42.34M | 79.96M | 3K | 603K |
Cash generated by investing activities | -22.12M | 39.95M | -81.90M | 15.59M | -5.87M |
Financing activities | |||||
Common Stock Issued | 105.95M | 7.82M | 119.58M | 1.01M | 1.59M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -40.15M | -121K | -27K | -142K | -185K |
Cash used in financing activities | 61.52M | 6.33M | 137.34M | 25.23M | 1.33M |
Net Change In Cash | -2.19M | -12.57M | 10.71M | 5.62M | -45.15M |
Cash at end of period | 10.40M | 12.59M | 25.17M | 14.45M | 8.83M |
| Data source | Data source |